Published in Drug Law Weekly, November 13th, 2007
"Our study demonstrates that it is feasible for head and neck cancer patients to receive IMRT in their own communities without sacrificing high-quality care," said Dwight Heron, M.D., associate professor of radiation oncology, University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-11-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.